BOSTON – Nanotechnology, though small in scale, is making a big difference in gastroenterology. Nanoparticles can deliver therapeutic compounds or enable other diagnostic tools, said Vadim Backman, PhD, the Walter Dill Scott Professor of Biomedical Engineering at Northwestern University, Chicago, in a video interview at the AGA Tech Summit, sponsored by the AGA Center for GI Innovation and Technology. Nanotechnology can treat disease by reprogramming gene expression or gene regulation. Nanoparticle formulations are FDA approved now for treatment of esophageal, colon, and pancreatic cancers, said Dr. Backman in a video interview, but the ability of nanotechnology to reprogram biological processes at the genetic level has researchers looking at treating inflammatory diseases and regenerating tissues.
AGA Tech Summit
VIDEO: Nanotechnology is making a mark in gastroenterology
Publish date: March 28, 2018
FROM THE 2018 AGA TECH SUMMIT
More IBD & Intestinal Disorders News
- Celiac disease: Update on diagnosis and monitoring
- Male IBD medication use doesn’t hamper reproduction, analysis suggests
- Mirikizumab performs well in UC new data show
- Surveillance colonoscopy: When and how to stop
- No link between PPIs and dementia in new study
- IBD study characterizes biologic adherence, confirms nonadherence risk factors
- Medtronic to discontinue SmartPill capsule
- AGA offers guidance on gastric peroral endoscopic myotomy for gastroparesis
Irritable Bowel Syndrome and Sleep
Question 1 of 5